Urinary Amino Acid Profiling as a Non-invasive Diagnostic and Risk Stratification Tool in Prostate Cancer
In Vivo · 2026
DOI: 10.21873/invivo.14262 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2026. Verfasst von Tereza Zdobinska und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic; tereza.zdobinska@fnmotol.cz. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Amino Acids, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND/AIM: Prostate cancer (PCa) is a leading malignancy in men worldwide. Despite its routine use, PSA testing lacks specificity and often results in unnecessary biopsies, especially in men with borderline PSA values. Urinary metabolomic profiling may offer a fully non-invasive approach to detect tumor-related metabolic alterations. Amino acids are of interest due to their roles in cancer metabolism, proliferation, and redox regulation. Building on our previous pilot study, we assessed whether urinary amino acid concentrations can differentiate PCa from benign cases, identify high-risk disease, and provide diagnostic information independent of prostate volume or prior prostate manipulation. PATIENTS AND METHODS: First-morning urine samples without prior prostate manipulation were collected from 90 men: 60 with histologically confirmed PCa and 30 healthy controls. Total urinary amino acids were quantified using high-performance liquid chromatography with fluorescence detection and normalized to creatinine. The primary analysis compared amino acid concentrations between PCa and controls. Secondary analyses assessed associations with PSA, prostate volume, lymph-node status, surgical margins, postoperative PSA detectability, and preoperative risk category. RESULTS: Significant alterations were observed in glutamate+glutamine (p=0.005), arginine (p=0.030), leucine (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic; tereza.zdobinska@fnmotol.cz.
- Institute of Medical Chemistry and Clinical Biochemistry, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
- Department of Urology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
- Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Zitieren
APA
Zdobinska, T., Luksanova, H., Duskova, K., Priman, O., Slavenko, M., Babjuk, M., & Vesely, S. (2026). Urinary Amino Acid Profiling as a Non-invasive Diagnostic and Risk Stratification Tool in Prostate Cancer. In Vivo. https://doi.org/10.21873/invivo.14262
Vancouver
Zdobinska T, Luksanova H, Duskova K, Priman O, Slavenko M, Babjuk M, et al. Urinary Amino Acid Profiling as a Non-invasive Diagnostic and Risk Stratification Tool in Prostate Cancer. In Vivo. 2026. doi:10.21873/invivo.14262
BibTeX
@article{Zdobinska2026,
author = {Zdobinska, Tereza and Luksanova, Hana and Duskova, Katerina and Priman, Ondrej and Slavenko, Matvei and Babjuk, Marko and Vesely, Stepan},
title = {Urinary Amino Acid Profiling as a Non-invasive Diagnostic and Risk Stratification Tool in Prostate Cancer},
journal = {In Vivo},
year = {2026},
doi = {10.21873/invivo.14262}
}
EUVIMED